A new documentary about Elizabeth Holmes, the founder of the ill-fated biotech company Theranos, is scheduled to hit cinemas on 16 October. Titled *You Can See Everything*, this film shines a spotlight on Holmes in the weeks leading up to her imprisonment earlier this year, following a conviction on multiple counts of fraud. The film had its premiere at the Telluride Film Festival on 6 September, generating a buzz that suggests it will be a significant release this autumn.
:max_bytes(150000):strip_icc():format(jpeg)/nathan-fielder-lance-oppenheim-elizabeth-holmes-0f5f3d11cf54460d996e98489f435da4.jpg)
Directed by Lance Oppenheim and Nathan Fielder, the documentary has garnered favourable reactions since its debut. It has particularly intrigued audiences about how the filmmakers managed to keep their project under wraps while collaborating with Holmes, now aged 42. Fielder, well-known for his work on *Nathan for You* and *The Rehearsal*, has brought his unique style to this documentary, blending elements of social commentary and dark humour.
Oppenheim, speaking with *PEOPLE*, revealed that the journey to create *You Can See Everything* was far from straightforward. “Well, not easily,” said the 30-year-old director, who has been involved in the project for nearly four years. He is also set to release his narrative film, *Primetime*, featuring Robert Pattinson as Chris Hansen from the show *To Catch a Predator*, which arrives in theatres on 25 September. Oppenheim expressed excitement about both films but preferred to maintain a level of mystery regarding the documentary ahead of its release, emphasising that a fresh perspective will enhance the viewing experience.
This upcoming release marks Oppenheim’s fourth and fifth feature films, as he has entered both the documentary and narrative filmmaking spaces. He praised Fielder’s influence during the production process, noting their longstanding friendship. “I’m very fortunate to him. I’m very grateful to him,” Oppenheim said. Their collaborative work extended beyond *You Can See Everything*, as both were also involved in multiple other projects concurrently, including *Ren Faire* and *Spermworld*.
As the accolades for *You Can See Everything* continue to pour in since its Telluride premiere, Oppenheim is preparing for its screening at the New York Film Festival on 30 September. He expressed bemusement at the attention surrounding his work, pointing out that a considerable part of their crew, including his wife Abigail Rowe, contributed to both films. This ongoing collaboration has fostered a close professional and personal relationship with his team.
Regarding what viewers might expect from the Holmes documentary, Oppenheim urges audiences to enter with minimal preconceptions. “I’m really excited for people to see it and to grapple with it,” he remarked, encouraging discretion around plot details. “If you’ve seen it, please tell people to go watch it. But if you see someone spoiling it, tell them not to because I think the experience of that movie is best served when you don’t know what’s happening in it.”
The director highlighted the initial reactions following the film’s Telluride screening, where many audience members grappled with the unfolding narrative. “I think that was a lot of the reaction that the film generated out of Telluride… was that people just couldn’t believe what they were watching,” he noted, advocating for an unspoiled experience for future audiences.
As Holmes serves an 11.25-year prison sentence due to her fraudulent activities leading to the collapse of Theranos, this documentary aims to explore the contours of her complex story. With a projected release date from prison on 30 December 2031, the public remains fascinated by her journey, and *You Can See Everything* may offer an important insight into her mindset during a tumultuous period.
The countdown to the film’s release has already begun, generating considerable excitement and building anticipation. As audiences prepare for the cinematic debut, Oppenheim and Fielder’s timely exploration of Holmes’s circumstances will likely spark discussions long after the credits roll in theatres.